Jonathan Fleming
Corporate Officer/Principal chez INTELLIGENT MEDICINE ACQUISITION CORP.
Profil
Jonathan J.
Fleming is the founder of MVP Ventures, which was founded in 1988.
He held the title of General Partner from 1988 to 1996.
Mr. Fleming is also the founder of Medica Venture Partners, QurAlis Corp., Enclear Therapies, Inc...
Mr. Fleming's current job(s) include Chairman at Onc.ai, Inc., Director at Continuus Pharmaceuticals, Inc., Treasurer & Director at New England Healthcare Institute, Director at Leerink Swann Investment Trust, Advisor at 20, Advisor at Novatio Ventures, Managing Partner at Pimlico Pond Investments LLC, and Advisor at Intelligent Medicine Acquisition Corp.
Mr. Fleming's former job(s) include President, Chief Executive Officer & Director at Q-State Biosciences, Inc., Chairman at Memory Pharmaceuticals Corp., Director at IMCOR Pharmaceutical Co., Director at Hypnion, Inc., Independent Director at Radius Health, Inc., Independent Director at Xencor, Inc., Director at Laboratory Partners, Inc., Director at Molecular Biometrics, Inc., Director at Dicerna Pharmaceuticals, Inc., Director at SVB Securities Holdings LLC, Director at Avaxia Biologics, Inc., Director at Elixir Pharmaceuticals, Inc., Director at Enanta Pharmaceuticals, Inc., Director at BioProcessors Corp., Non-Executive Director at BioSeek Plc, Director at Collgard Biopharmaceuticals Ltd., Director at superDimension, Inc., Director at GreenLight Biosciences, Inc., Director at RailRunner N.A., Inc., Director at EightSpokes, Inc., and Managing Partner at Oxford Bioscience Partners.
Mr. Fleming also served as a Trustee at the Museum of Science.
Mr. Fleming's education includes a graduate degree from Princeton University and an undergraduate degree from the University of California, Berkeley.
Postes actifs de Jonathan Fleming
| Sociétés | Poste | Début |
|---|---|---|
| INTELLIGENT MEDICINE ACQUISITION CORP. | Corporate Officer/Principal | - |
New England Healthcare Institute
 New England Healthcare Institute Miscellaneous Commercial ServicesCommercial Services New England Healthcare Institute operates as a national nonprofit, nonpartisan organization composed of stakeholders from across all key sectors of health and health care. The company was founded by Henri A. Termeer in 2002 and is headquartered in Boston, MA. | Director/Board Member | - |
Enclear Therapies, Inc.
 Enclear Therapies, Inc. Pharmaceuticals: MajorHealth Technology Enclear Therapies, Inc. develops and manufactures novel device-based therapies to treat patients. The firm device is developed to treat and halt the progression of neurodegenerative diseases by removing toxic proteins known to drive pathology. The company was founded by Anthony R. DePasqua, Jonathan J. Fleming, Kasper Roet, William B. Gormley and Kevin Eggan and is headquartered in Newburyport, MA. | Founder | - |
Continuus Pharmaceuticals, Inc.
 Continuus Pharmaceuticals, Inc. Packaged SoftwareTechnology Services Continuus Pharmaceuticals, Inc. engages in the development continuous manufacturing platform. It offers ICM (Integrated Continuous Manufacturing), which enables non-stop processes that incorporate API formation steps with final drug product formulation. The company was founded was founded by Salvatore Mascia and Bayan Takizawa in 2012 and is headquartered in Woburn, MA. | Director/Board Member | 01/01/2014 |
Onc.ai, Inc.
 Onc.ai, Inc. Packaged SoftwareTechnology Services Onc.ai, Inc. is a digital health company that is privately held and is developing a precision oncology care management platform. The company is based in San Carlos, CA. The company aims to transform clinical decision making and is backed by premier investment firms such as the Blue Venture Fund, MassMutual Alternative Investments, and Accomplice, among others. The company is building a pipeline of physician-centered products to fulfill the potential of precision oncology. The company was founded by Akshay Nanduri, who has been the CEO since incorporation. | Chairman | - |
| Pimlico Pond Investments LLC | Corporate Officer/Principal | - |
20/20 HealthCare Partners LLC
 20/20 HealthCare Partners LLC Investment ManagersFinance 20/20 HealthCare Partners LLC (20/20 HealthCare Partners) is a venture capital firm founded in 2005 by Hillel Bachrach. The firm is headquartered in Auburndale, Massachusetts. | Consultant / Advisor | - |
| Leerink Swann Investment Trust | Director/Board Member | 29/11/2010 |
Novatio Ventures
 Novatio Ventures Investment ManagersFinance Novatio Ventures (Novatio Ventures) is a venture capital firm founded in 2015 by Peng Fu. The firm is headquartered in Toronto, Canada. | Consultant / Advisor | - |
Anciens postes connus de Jonathan Fleming
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formation de Jonathan Fleming
| Princeton University | Graduate Degree |
| University of California, Berkeley | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| XENCOR, INC. | Health Technology |
| ENANTA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 32 |
|---|---|
Oxford Bioscience Partners
 Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston. | Finance |
IMCOR Pharmaceutical Co.
 IMCOR Pharmaceutical Co. Medical SpecialtiesHealth Technology IMCOR Pharmaceutical Co. is a development-stage pharmaceutical company focused on developing medical imaging pharmaceutical products. Currently, the company's core business focus has evolved from an operating entity conducting research and development, manufacturing and limited selling activities. The company was founded by H. Craig Dees and Eric A. Wachter on December 28, 1994 and is headquartered in San Diego, CA. | Health Technology |
Hypnion, Inc.
 Hypnion, Inc. Miscellaneous Commercial ServicesCommercial Services Hypnion, Inc. discovered and developed neuroscience drugs. It focused on the development of novel therapeutics for the treatment of central nervous system disorders to serve the underserved markets of sleep and wake-alertness disorders and circadian rhythm abnormalities. The company was founded in 2000 and was headquartered in Lexington, MA. | Commercial Services |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Laboratory Partners, Inc.
 Laboratory Partners, Inc. Medical/Nursing ServicesHealth Services Laboratory Partners Inc. provides clinical diagnostic testing services. Its services include clinical laboratory, pathology, and cytology services. The firm offers services for hospitals, skilled nursing facilities, physician offices, and clinics. The company was founded in 2004 and is headquartered in Cincinnati, OH. | Health Services |
Molecular Biometrics, Inc.
 Molecular Biometrics, Inc. Miscellaneous Commercial ServicesCommercial Services Molecular Biometrics, Inc. used to develop analytical methodologies for molecular diagnostic. It developed highly specific and sensitive analytical methodologies for molecular diagnostic and monitoring applications in medicine, and for drug discovery and development through pharmacodiagnostics. The company was founded in 2005 and was headquartered in Norwood, MA. | Commercial Services |
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
SVB Securities Holdings LLC
 SVB Securities Holdings LLC Financial ConglomeratesFinance SVB Leerink Holdings LLC operates as an investment bank holding company with interest in investment services. The firm provides equity research, institutional sales and trading, corporate finance and strategic advisory services. The company was founded in 1995 and is headquartered in Boston, MA. | Finance |
Avaxia Biologics, Inc.
 Avaxia Biologics, Inc. BiotechnologyHealth Technology Avaxia Biologics, Inc. operated as a clinical-stage biotechnology company. It engaged in the development of gut-targeted antibody therapeutics for gastroenterology indications. Gut-targeted antibody therapeutics is orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal (GI) tract including the mouth, throat, and intestines. The company was founded by David Poorvin and Barbara S. Fox in 2005 and was headquartered in Lexington, MA. | Health Technology |
Continuus Pharmaceuticals, Inc.
Continuus Pharmaceuticals, Inc. Packaged SoftwareTechnology Services Continuus Pharmaceuticals, Inc. engages in the development continuous manufacturing platform. It offers ICM (Integrated Continuous Manufacturing), which enables non-stop processes that incorporate API formation steps with final drug product formulation. The company was founded was founded by Salvatore Mascia and Bayan Takizawa in 2012 and is headquartered in Woburn, MA. | Technology Services |
Elixir Pharmaceuticals, Inc.
 Elixir Pharmaceuticals, Inc. Investment Trusts/Mutual FundsMiscellaneous Elixir Pharmaceuticals, Inc. operates as a holding company with interest in manufacturing and developing biopharmaceutical products for the treatment of metabolic diseases such as diabetes and obesity. The company was founded by Leonard Guarente, Cynthia J. Kenyon, Cindy Bayley, Louis Kunkel, Annibale Puca, and Thomas Perls in 1999 and is headquartered in Cambridge, MA. | Miscellaneous |
Memory Pharmaceuticals Corp.
 Memory Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Memory Pharmaceuticals Corp. develops pharmaceutical products for the treatment of debilitating central nervous system (CNS) disorders such as Alzheimer's disease and schizophrenia. The company was founded by Axel Unterbeck in 1998 and is headquartered in Montvale, NJ. | Health Technology |
BioProcessors Corp.
 BioProcessors Corp. Electronic Equipment/InstrumentsElectronic Technology BioProcessors, Inc. provides micro-engineered solutions for the biotechnology and pharmaceutical industry. It offers biomanufacturing workflow methods and technologies that help scientists to optimize the process development. The company was founded by Andrey Zarur in October 2000 and is located in Woburn, MA. | Electronic Technology |
Medica Venture Partners
 Medica Venture Partners Investment ManagersFinance Medica Venture Partners (Medica Venture Partners) is a venture capital firm founded in 1995 by Yuval Binur, Ehud Geller and Jonathan Fleming. The firm is headquartered in Israel. | Finance |
BioSeek Plc
 BioSeek Plc Miscellaneous Commercial ServicesCommercial Services BioSeek Plc provides human tissue-based research services for the pharmaceutical industry. It focuses on applying human primary cell assays and predictive disease models to the discovery and development of human therapeutics and safer chemicals. The company was founded by Eugene Butcher in March 1996 and is headquartered in London, the United Kingdom. | Commercial Services |
Museum of Science
 Museum of Science Other Consumer ServicesConsumer Services Museum of Science operates as a museum. The company was founded in 1830 and is headquartered in Boston, MA. | Consumer Services |
New England Healthcare Institute
New England Healthcare Institute Miscellaneous Commercial ServicesCommercial Services New England Healthcare Institute operates as a national nonprofit, nonpartisan organization composed of stakeholders from across all key sectors of health and health care. The company was founded by Henri A. Termeer in 2002 and is headquartered in Boston, MA. | Commercial Services |
Collgard Biopharmaceuticals Ltd.
 Collgard Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Collgard Biopharmaceuticals, the tissue therapeutics company, is developing drug treatments that target disease progression by directly influencing the tissue regeneration process. Central to Collgard's novel approach is its lead drug candidate, Tempostatin (Halofuginone hydrobromide). Tempostatin is a multi-indication, small-molecule drug candidate that has been identified by the company as influencing a 'master switch' in the body's tissue repair process. As a potent and selective regulator of stromal cell activation, cell migration and excessive collagen type I synthesis, Tempostatin makes it possible to harness and direct the tissue repair process for treating diseases acting at the tissue level. Collgard is developing therapeutic solutions for several clinical indications with significant unmet clinical needs. These solutions are based on highly specific control of the tissue repair process. Current programs target the following indications vascular restenosis, end-organ fibrosis, selected cancers and dermal fibroproliferative disorders. Tempostatin holds exceptional promise based on addressing a fundamental underlying pathological process that is not accessible to other current therapeutic approaches. In developing Tempostatin, Collgard seeks to offer novel therapeutic solutions as well as extend the effectiveness of existing therapies. Founded in 1996, Collgard Biopharmaceuticals is a privately held, clinical stage company, led by a global team of medical and drug development experts based in Atlanta and Tel Aviv. Scientific and clinical collaborators include The Mayo Clinic, the U.S. NCI, the EORTC, and Harvard Medical School. Collgard was founded by Medica Venture Partners. Additional investors include Mayo Medical Ventures, Denali Ventures, Yozma Group, and Comsor. | Health Technology |
20/20 HealthCare Partners LLC
20/20 HealthCare Partners LLC Investment ManagersFinance 20/20 HealthCare Partners LLC (20/20 HealthCare Partners) is a venture capital firm founded in 2005 by Hillel Bachrach. The firm is headquartered in Auburndale, Massachusetts. | Finance |
superDimension, Inc.
 superDimension, Inc. Medical SpecialtiesHealth Technology SuperDimension, Inc. used to develop and market pulmonology devices. It developed and used to market catheter-based devices for use in the invasive diagnosis and treatment of early stage lung cancer and other diseases, using the patient's natural airways to avoid surgery. The company was founded by Pinhas Gilboa in 1995 and was headquartered in Minneapolis, MN. | Health Technology |
GreenLight Biosciences, Inc.
 GreenLight Biosciences, Inc. BiotechnologyHealth Technology GreenLight Biosciences, Inc. engages in a biotechnology company.. It delivers attractive solution for production of chemicals and fuels from renewable resources, eliminating the need for petroleum feedstocks. The company was founded by Andrey J. Zarur, Marta Ortega-Valle, and James R. Swartz and is headquartered in Medford, MA. | Health Technology |
| Leerink Swann Investment Trust | |
RailRunner N.A., Inc.
 RailRunner N.A., Inc. RailroadsTransportation RailRunner N.A., Inc. develops Road-Ready bi-modal rail system, a railcar, trailer, and container chassis system that is enabling container-based intermodal transportation service to a market of manufacturers, farmers, shippers, wholesalers, and retailers who are not located near traditional intermodal hubs. The company is headquartered in Waltham, MA. | Transportation |
EightSpokes, Inc.
 EightSpokes, Inc. Packaged SoftwareTechnology Services EightSpokes, Inc. develops a SaaS platform for execution of management life cycle initiatives such as product development, global product launches, and lifecycle management of in-market products. Its software solution Enlighten, a management software that replace the majority of the manual planning, coordination and communication problems that occur. The company was founded in 2012 and is headquartered in Cambridge, MA. | Technology Services |
Q-State Biosciences, Inc.
 Q-State Biosciences, Inc. BiotechnologyHealth Technology Q-State Biosciences, Inc. operates as Biotechnology Company. It offers cardiology, neurology, toxicity screening, drug discovery, drug efficacy screening, pathology modeling, optogenetic, electrophysiology, voltage and calcium signal. The company was founded by Adam E. Cohen, Kevin Eggan, David Margulies and Joel Kralj and is headquartered in Cambridge, MA. | Health Technology |
QurAlis Corp.
 QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | Health Technology |
Enclear Therapies, Inc.
Enclear Therapies, Inc. Pharmaceuticals: MajorHealth Technology Enclear Therapies, Inc. develops and manufactures novel device-based therapies to treat patients. The firm device is developed to treat and halt the progression of neurodegenerative diseases by removing toxic proteins known to drive pathology. The company was founded by Anthony R. DePasqua, Jonathan J. Fleming, Kasper Roet, William B. Gormley and Kevin Eggan and is headquartered in Newburyport, MA. | Health Technology |
Novatio Ventures
Novatio Ventures Investment ManagersFinance Novatio Ventures (Novatio Ventures) is a venture capital firm founded in 2015 by Peng Fu. The firm is headquartered in Toronto, Canada. | Finance |
| Pimlico Pond Investments LLC | |
Onc.ai, Inc.
Onc.ai, Inc. Packaged SoftwareTechnology Services Onc.ai, Inc. is a digital health company that is privately held and is developing a precision oncology care management platform. The company is based in San Carlos, CA. The company aims to transform clinical decision making and is backed by premier investment firms such as the Blue Venture Fund, MassMutual Alternative Investments, and Accomplice, among others. The company is building a pipeline of physician-centered products to fulfill the potential of precision oncology. The company was founded by Akshay Nanduri, who has been the CEO since incorporation. | Technology Services |
Intelligent Medicine Acquisition Corp.
 Intelligent Medicine Acquisition Corp. Electrical ProductsProducer Manufacturing Intelligent Medicine Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Bethesda, MD. | Producer Manufacturing |
| MVP Ventures |
